Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial.
Lopardo G, Belloso WH, Nannini E, Colonna M, Sanguineti S, Zylberman V, Muñoz L, Dobarro M, Lebersztein G, Farina J, Vidiella G, Bertetti A, Crudo F, Alzogaray MF, Barcelona L, Teijeiro R, Lambert S, Scublinsky D, Iacono M, Stanek V, Solari R, Cruz P, Casas MM, Abusamra L, Luciardi HL, Cremona A, Caruso D, de Miguel B, Lloret SP, Millán S, Kilstein Y, Pereiro A, Sued O, Cahn P, Spatz L, Goldbaum F; INM005 Study Group. Lopardo G, et al. Among authors: teijeiro r. EClinicalMedicine. 2021 Apr;34:100843. doi: 10.1016/j.eclinm.2021.100843. Epub 2021 Apr 11. EClinicalMedicine. 2021. PMID: 33870149 Free PMC article.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial.
Han MK, Antila M, Ficker JH, Gordeev I, Guerreros A, Bernus AL, Roquilly A, Sifuentes-Osornio J, Tabak F, Teijeiro R, Bandelli L, Bonagura DS, Shu X, Felser JM, Knorr B, Cao W, Langmuir P, Lehmann T, Levine M, Savic S. Han MK, et al. Among authors: teijeiro r. Lancet Rheumatol. 2022 May;4(5):e351-e361. doi: 10.1016/S2665-9913(22)00044-3. Epub 2022 Mar 29. Lancet Rheumatol. 2022. PMID: 35368384 Free PMC article.
Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension.
Sandoval J, Del Valle-Mondragón L, Masso F, Zayas N, Pulido T, Teijeiro R, Gonzalez-Pacheco H, Olmedo-Ocampo R, Sisniega C, Paez-Arenas A, Pastelin-Hernandez G, Gomez-Arroyo J, Voelkel NF. Sandoval J, et al. Among authors: teijeiro r. Eur Respir J. 2020 Jul 23;56(1):1902416. doi: 10.1183/13993003.02416-2019. Print 2020 Jul. Eur Respir J. 2020. PMID: 32241831 Free article.
Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.
Gamboa-Cárdenas RV, Ugarte-Gil MF, Massardo L, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA. Gamboa-Cárdenas RV, et al. Among authors: teijeiro r. Clin Rheumatol. 2019 Oct;38(10):2963-2964. doi: 10.1007/s10067-019-04742-8. Clin Rheumatol. 2019. PMID: 31432337
Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.
Gamboa-Cárdenas RV, Ugarte-Gil MF, Loreto M, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA. Gamboa-Cárdenas RV, et al. Among authors: teijeiro r. Clin Rheumatol. 2019 Oct;38(10):2737-2746. doi: 10.1007/s10067-019-04618-x. Epub 2019 Jun 3. Clin Rheumatol. 2019. PMID: 31161486
34 results